A LIMS implementation checklist lists what a lab must finish before go-live, what it must verify in the first 72 hours, and what it must review in the first 90 days. For a clinical lab, the critical items are documented workflows, a scoped data migration, verified interfaces and result reporting, role-based access, trained staff, a parallel run, and a downtime plan. Most rollouts that struggle skip one of these, not the software selection.
LIMS Implementation Checklist at a Glance
| Stage | Timing | Key tasks | Typical owner | Done when |
| Workflow documentation | Days 1–14 | Map real workflows, interfaces, test menu, report templates | Lab manager, supervisors | Every workflow and exception is written down and signed off |
| Data migration scoping | Days 7–21 | Decide what migrates and what stays read-only; clean legacy data | LIS/IT lead | Migration list agreed; retention plan for legacy records confirmed |
| Integration planning | Days 14–30 | Confirm interface specs and build timelines; test in staging | LIS/IT lead, vendor | Every interface passes end-to-end tests in staging |
| User and role setup | Days 21–45 | Assign least-privilege roles; validate QC and auto-verification rules | Lab director, LIS lead | Roles approved; rules verified against expected results |
| Training | Days 30–60 | Role-based and scenario training; name super users | Supervisors, super users | Each user completes training for their role |
| Go-live | First 72 hours | Final verification checklist; parallel run; downtime plan ready | Implementation team | Parallel run criteria met; no open critical issues |
| Post-go-live | Days 1–90 | 30-day fixes, 60-day optimization, 90-day baseline | Lab manager | Baseline metrics recorded; open issues have owners |
Most LIMS implementations don’t fail because the software is wrong. They fail because the lab isn’t ready, and nobody told them what “ready” looks like.
By the time a go-live date is on the calendar, most lab directors have already spent months evaluating vendors, negotiating contracts, and reviewing feature demonstrations.
What they haven’t done is the harder, less glamorous work. They haven’t mapped the workflow exceptions that live only in staff memory. They haven’t audited years of inconsistent test coding. And they haven’t asked the vendor to confirm in writing that it supports their analyzer interface.
That work doesn’t happen in a sales cycle. It has to happen in the 60 days before go-live, or it surfaces on Day One, in production, with real patient samples.
The labs that went live without chaos were the ones that treated implementation as a project, not an event. This checklist is what that project looks like.
PRE-IMPLEMENTATION: The 30–60 Day Runway
The Standish Group’s 2015 CHAOS Report found that only 29% of IT projects finish on time, on budget, and with the features originally required (InfoQ summary). In healthcare IT specifically, Gartner estimates that roughly 75% of implementations experience cost overruns, schedule slippage, or both. LIMS projects are not exempt from this pattern. The variable that separates the 29% from the rest is almost always what happened, or didn’t happen, in the weeks before go-live.
Phase 1: Current-State Workflow Documentation (Days 1–14)
The first mistake most labs make is documenting how workflows should work. The SOP binder is not the truth.
The truth is the workaround the night-shift tech uses because no one updated the SOP after the lab replaced the centrifuge. It’s the unwritten rule staff follow when a sample from a particular referring physician arrives without a requisition.
- Map every clinical workflow from patient registration to result delivery, not the designed version, but the operational one. You need someone to walk the floor, watch each station, and ask, “What do you do when X happens?” Their notes become your configuration input.
- At the same time, catalog every instrument interface you’re running: model, manufacturer, current protocol (ASTM, HL7), and whether the interface is bidirectional or unidirectional. Unidirectional interfaces that need to become bidirectional in the new system require interface builds; those take time, and you need to know now.
- Audit your test menu completely: test codes, reference ranges, reportable units, autoverification rules, critical value thresholds, and reflex testing logic. All delta check parameters. Every auto-approval rule. You must configure all of these in the new system. Wrong source data means a wrong configuration.
- Finally, pull all your current report templates. Flags that are standard and which have custom, client-specific layouts, state-required formats, and send-out reference ranges. Custom templates take build time. Count them.
Phase 2: Data Migration Scoping (Days 7–21)
The data migration question that matters most is not “can we migrate it?” But “should we migrate it?” Historical data migration is expensive, complex, and often responsible for a significant share of implementation delays and budget overruns. Make deliberate decisions about scope before your vendor starts quoting the migration effort.
Read-only does not mean disposable. CLIA requires labs to keep test requisitions, test records and test reports for at least two years, and pathology reports for at least 10 years (42 CFR 493.1105). Whatever you leave in the legacy system must stay retrievable for those periods. Decide now who maintains access to the old system or its archive, and test that you can pull a report from it after go-live.
- Define what must come over: pending orders, active patient demographics, recent results (what time window?), and open QC records. Define what can be archived and accessed from the legacy system on a read-only basis. Most historical result data falls into the second category: queryable if you need it, but not worth migrating at cost.
- Once the scope is defined, run a data quality audit on your legacy system. What you’ll find in most labs running LIS systems that are more than five years old: duplicate patient records (sometimes thousands), inconsistent test codes across locations, and result records with missing or corrupted fields. Every dirty record is a migration exception. Find them now, not during the cutover.
- Pin down your migration cutover date and negotiate a parallel-run window with your vendor. The minimum acceptable parallel run is 5–7 business days, both systems running simultaneously, and results confirmed to match before exclusive operation in the new system begins. Labs that skip the parallel run and go directly to new-system-only are accepting unnecessary risk with patient data.
Phase 3: Integration Planning (Days 14–30)
Instrument interface support must be confirmed in writing, with interface build SLAs. “We support that analyzer” is not a confirmation. What you need is: which specific interface protocol will be used, who builds the interface (vendor or their partner), what the build timeline is, and what the acceptance testing process looks like. Get this in writing before your go-live date is set; otherwise, your go-live date may be set around an interface that isn’t finished.
- Map all third-party integrations: EHR/EMR, billing platform, reference lab portals, payer systems, and patient portal. Each integration is a separate build and a separate go-live dependency. If your billing integration isn’t ready, you can’t bill on Day One. Prioritize accordingly.
- Establish a staging environment with test data for each interface. Integration testing should happen in staging, repeatedly, before anything touches production. If your LIMS vendor doesn’t provide a staging environment for integration testing, that’s a question worth raising before you’ve signed the contract.
- Verify every interfaced result end to end. Send known test results through each analyzer, middleware, EHR and reference-lab interface, and confirm they reach the final report unchanged. Under CLIA, the lab must have systems in place to ensure results are sent accurately and reliably from the point of data entry, whether interfaced or entered manually, to the final report destination (42 CFR 493.1291(a)).
- Test the rules that change results, not just the connections. Check calculations, reference intervals, critical values and auto-verification rules against expected outputs. These are the areas accreditation checklists focus on (ADLM, 2026).
Also add to the Go-Live verification list:
- Every interface has been verified with known results, and the verification is documented.
- Calculated results, reference intervals and critical-value flags match the legacy system for the same test patients.
Phase 4: User and Role Configuration (Days 21–45)
Define all user roles and permission levels using RBAC principles, least privilege, not convenience. Front desk staff don’t need to access QC records. Phlebotomists don’t need to release results. Lab technicians don’t need billing data. Map your current staff to the new system’s role structure before go-live; don’t configure permissions on the fly after users start logging in.
Least privilege is also a regulatory expectation. The HIPAA Security Rule requires access controls that limit electronic protected health information to the people and roles that need it (HHS). Document who approved each role, and remove legacy-system access for staff who no longer need it after go-live.
QC rules, auto-verification parameters, and critical-value alert routing should all be configured and validated in staging, not on go-live day. This is the configuration category that gets skipped when timelines are compressed. The lab goes live with default QC rules and placeholder autoverification thresholds, then spends the next six weeks cleaning up the downstream consequences.
Phase 5: Training Plan Execution (Days 30–60)
Role-based training, not department-wide training. Front desk registration staff, phlebotomists, bench technicians, supervisors, billing staff, and IT each need different training content. Running them through the same session wastes everyone’s time and leaves the bench tech uncertain about billing workflows that don’t apply to her job.
Train on real test cases in the staging environment. Hypothetical click-throughs don’t prepare staff for the actual workflow. A hematology tech needs to process a CBC panel, trigger a delta check, and follow the autoverification rule in the training environment before go-live. That’s what builds muscle memory.
Designate super users at each site. These are the staff members who get extended training and become the first call when a colleague is stuck. They are not IT. They are lab professionals who know the workflow and the system. Post go-live, the presence or absence of capable super users is usually the single biggest factor in how smooth the first 30 days feel.
Go – LIVE: The Critical 72 Hours
No surprises should emerge in the first 72 hours; every system and workflow should already have been tested in staging. The go-live checklist is a verification exercise, not a configuration exercise.
Before the first patient is registered in the new system, confirm:
- All instrument interfaces tested and confirmed bidirectional in the production environment (not staging)
- All QC rules and autoverification parameters validated in production
- All user accounts are active with confirmed access rights
- Critical value alert routing tested with a real test case
- Report delivery (fax, portal, email) tested with documented confirmation
- Billing integration confirmed with at least three test claims submitted and acknowledged
- Patient registration workflow completed end-to-end with a test patient
- Vendor on-call contact confirmed and distributed to all staff and site supervisors.
- Brief the teams upstream of the lab – ordering clinicians, phlebotomy and nursing – on any change to ordering, labeling or specimen collection. Deviations upstream are a common source of go-live problems.
Parallel Run Protocol
Run the old and new systems side by side until you meet both conditions: at least 5 to 7 business days have passed, and your 50 highest-volume tests produce matching results, flags and reports in both systems. Use whichever comes later. Compare a sample of reports line by line each day, and log every mismatch with an owner.
Post – Implementation: The First 90 Days
Go-live is not the finish line. This is where the optimization begins, and where most implementation failures originate. The labs that struggle in the post-go-live period are usually the ones that didn’t have a structured plan for the first 90 days.
30-Day Post-Go-Live Checklist
- Identify and resolve all open instrument interface issues (there will be some).
- Review TAT data in the new system and compare it to your legacy baseline, specifically for high-volume panels and any test types with known variability
- Complete the first billing reconciliation cycle and confirm that the denial rate in the new system matches or improves on the legacy baseline; if denials are higher, investigate by CPT code immediately
- Complete the first supervisory QC review using the new system data
- Collect staff feedback systematically, a structured survey by role is better than anecdotal reports from the most vocal complainers.
- Check billing accuracy for panels and multi-site technical charges, and confirm that send-out tests carry the right pre-authorization.
- Confirm that results migrated from the legacy system display correctly in patient history and delta checks.
The 30 day mark is when instrument interface issues that weren’t caught during parallel running will surface. Budget time for them. They are normal. These are not a vendor failure or an implementation failure; they are the inevitable friction of connecting complex systems. The failure mode is not having a resolution process.
60-Day Optimization Review
At 60 days, compare actual usage against the configured workflow. What you’ll typically find: gaps between how the workflow was designed and how staff are using the system. A workaround has already emerged somewhere; find it before it becomes permanent. Analyze which autoverification rules are flagging for manual review at rates higher or lower than expected, and adjust parameters accordingly. Retrain where the gap indicates a training failure rather than a configuration problem.
90-Day Performance Baseline
By 90 days, you have enough production data to establish your new performance baseline. Set it. TAT by test type, QC failure rate, billing denial rate, and sample rejection rate; these are the numbers against which you’ll measure every operational improvement going forward. Labs that don’t establish this baseline at 90 days tend to lose track of where they started, which makes it impossible to demonstrate ROI on the implementation investment.
A LIMS ROI case isn’t built on configuration; it’s built on documented performance improvements over time. The 90-day baseline is where that documentation begins.
Frequently Asked Questions About LIMS Implementation.
For a clinical lab, the final preparation and go-live stage covered in this checklist takes about 60 days, followed by 90 days of stabilization. The full project, including selection, contracting and build, usually takes longer and depends on the number of interfaces, sites and tests. See LIMS implementation cost by lab size for how scope drives effort.
Documenting the official workflow instead of the real one, migrating dirty legacy data, testing interfaces only for connectivity and not for correct results, skipping the parallel run, training everyone the same way, and having no downtime plan.
Run the old and new systems in parallel until results match, keep downtime procedures ready, schedule go-live outside your highest-volume days, and put super users at the bench for the first week.
Keep the first release to your standard test menu and core interfaces, migrate only active data, and add custom reports and secondary interfaces after go-live. Smaller labs can read how to select a feasible LIMS for a small lab.
Fixing interface and configuration issues found after go-live, tuning auto-verification and reports, retraining where usage differs from the design, and setting baseline metrics at 90 days. Agree the vendor’s support response times before go-live.
Operational gains such as fewer manual entries and fewer status calls usually show within the first months. Use the 90-day baseline in this checklist – turnaround time, QC failures, rejection rates and billing denials – as the starting point for measuring return.
Train by role instead of training everyone on everything, use scenario-based practice in a staging system, and give each shift a named super user. See how LIMS training improves staff efficiency
Conclusion
Implementation Is Not the Destination. It’s the Foundation.
LIMS go-live is not the finish line. The value of the investment is realized in the operational improvements that become possible once the platform is live and your staff is proficient, faster TAT, cleaner autoverification, more accurate billing, real-time visibility into QC events and inventory. None of that is possible on Day One. It’s possible at Day 90, Day 180, Day 365, if the implementation was done right.
The checklist above is not a guarantee of a smooth go-live. No checklist is. But the labs that treat implementation as a planning project, not a vendor handoff, are the ones that reach that 90-day baseline without the backlog of unresolved issues, the staff resistance born of inadequate training, and the billing exceptions that linger for quarters because the integration was never properly tested.
If you are planning a go-live, book a demo to see how CrelioHealth runs this checklist with labs like yours.
